Amount Raised
$200 Million
Round Type
Funding Round
CarlsbadBiotechnologyHealth CareTherapeuticsInvestors
Description
On September 14, 2026, Tyra Biosciences, Inc. entered into an underwriting agreement for the issuance and sale of common stock and pre-funded warrants. The company intends to raise a total of $200 million in this funding round. This agreement involves the sale of over 9 million shares at an offering price of $22.03 per share
Quick answer
Tyra Biosciences raised $200 Million in a Funding Round round, dated September 15, 2026. Investors: Guggenheim Securities, LLC, Jefferies LLC, Barclays Capital Inc. and Cantor Fitzgerald & Co. Tyra Biosciences is based in Carlsbad, California, United States.
- How much did Tyra Biosciences raise?
- Tyra Biosciences raised $200 Million in a Funding Round round on September 15, 2026.
- Who invested in Tyra Biosciences?
- Guggenheim Securities, LLC, Jefferies LLC, Barclays Capital Inc. and Cantor Fitzgerald & Co. are named as investors in this round.
- What does Tyra Biosciences do?
- Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology.
- Where is Tyra Biosciences based and how big is it?
- Tyra Biosciences is based in Carlsbad, California, United States. Fundz records about 87 employees.
- Who are the decision-makers at Tyra Biosciences?
- Fundz holds 1 contact at Tyra Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Tyra Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Setara Biosciences raised $90M (Series A) on October 30, 2026.
- StimCardio raised $30M (Series A) on October 29, 2026.
- Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
- Tivic raised $85M (Series B) on October 27, 2026.
- VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
Who to call at Tyra Biosciences, and when
A new round usually means Tyra Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tyra Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tyra Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tyra Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tyra Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tyra Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.